Overview

Adjuvant Chemotherapy in Patients With Lymph Node Metastasis After Radical Surgery in Cervical Cancer

Status:
Unknown status
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Purpose Primary endpoint - To evaluate the 3-year disease free survival Second endpoints - To evaluate the 3-year & 5-year overall survival To analyze the toxicity and the quality of life
Phase:
Phase 2
Details
Lead Sponsor:
Korean Gynecologic Oncology Group
Treatments:
Cisplatin
Paclitaxel